Home Newsfeeds Reuters Reported Earlier: Vaccine Makers, Including GSK, Moderna, Sanofi Developing Bird Flu Shots For Humans

News

Reuters Reported Earlier: Vaccine Makers, Including GSK, Moderna, Sanofi Developing Bird Flu Shots For Humans

https://www.reuters.com/business/healthcare-pharmaceuticals/vaccine-makers-prep-bird-flu-shot-humans-just-case-rich-nations-lock-supplies-2023-03-20/

byCharles Gross

March 20, 2023

1 minute read

https://www.reuters.com/business/healthcare-pharmaceuticals/vaccine-makers-prep-bird-flu-shot-humans-just-case-rich-nations-lock-supplies-2023-03-20/

News

Plug Power Starts Production Of Liquid Green Hydrogen At Its Georgia Plant; Shares Spike Higher

By Benzinga Newsdesk

January 23, 10:08 AM

Landmark Achievement for Plug's Vertically Integrated Green Hydrogen Ecosystem and the Largest Proton Exchange Membrane (PEM) Electrolyzer in the United States Plant is a First-Hand Customer Showcase for

PLUG

Marques Brownlee Mourns Fisker’s Bankruptcy: ‘Need More Competition In The EV Space, But This One Never Made It Over The Hill’

By Benzinga Neuro

June 18, 9:33 PM

Marques Brownlee, the prominent tech YouTuber known as MKBHD, expressed his disappointment over the bankruptcy of Fisker Inc., underlining the need for more competition in the electric vehicle sector.

FSRN

$1000 Invested In This Stock 15 Years Ago Would Be Worth $27,000 Today

By Benzinga Insights

September 16, 11:13 AM

Amazon.com (NASDAQ:AMZN) has outperformed the market over the past 15 years by 18.01% on an annualized basis producing an average annual return of 24.41%. Currently, Amazon.com has a market capitalization of $1.25 trillion.

AMZN

Stocks Open Higher; US Trade Deficit Widens In April

By Lisa Levin

June 7, 9:47 AM

U.S. stocks traded mostly higher this morning, with Nasdaq Composite gaining over 75 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.05% to 33,590.92 while the NASDAQ rose 0.55% to 13,349.38. The S&P 500, also rose, gaining, 0.18% to 4,291.74.

BASE

Reuters Reported Earlier: Vaccine Makers, Including GSK, Moderna, Sanofi Developing Bird Flu Shots For Humans

Related Posts

Plug Power Starts Production Of Liquid Green Hydrogen At Its Georgia Plant; Shares Spike Higher

Marques Brownlee Mourns Fisker’s Bankruptcy: ‘Need More Competition In The EV Space, But This One Never Made It Over The Hill’

$1000 Invested In This Stock 15 Years Ago Would Be Worth $27,000 Today

Stocks Open Higher; US Trade Deficit Widens In April